SALT LAKE CITY, UT--(Marketwire - Jan 3, 2013) - Q Therapeutics, Inc., an emerging biotechnology company developing innovative cell therapy products for the treatment of debilitating diseases of the central nervous system, today announced that the Company is scheduled to present at the Biotech Showcase™ 2013 to be held next week in San Francisco, California, January 7-9, 2013, during the JP Morgan Healthcare Conference.
The Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences.
EVENT AT A GLANCE
Deborah Eppstein, PhD - President and CEO
Steve Borst - CFO and Vice President, Corporate Development
Regenerative Medicine Track
Tuesday, January 8, 2013
11:00 AM PT
Parc 55 Wyndham San Francisco - Union Square
55 Cyril Magnin Street
San Francisco, California
NOTE TO PRESS:
Qualified media are also invited to attend the event on a complimentary basis. Please contact Justine Griego from EBD Group at 760-930-0500 or email@example.com to register for the event. To arrange one-on-one interviews with the executive management team of Q Therapeutics, please contact Erin Palmer at Hanover|Elite at 407-585-1080 or via email at QCEL@hanoverelite.com for scheduling details.
About Biotech Showcase (Innovation - Opportunity - Collaboration)
Now in its fifth year, Biotech Showcase will feature corporate presentations by 195 innovative life science companies to an audience of public and private investors, business development executives and professional advisors who are interested in investment opportunities and collaboration. Biotech Showcase takes place during the week of one of the most important healthcare investor conferences, which annually attracts thousands of healthcare and life science business executives to San Francisco in a venue located close to the center of action. Public and private investors are always invited to attend on a complimentary basis. Biotech Showcase was co-founded by Demy-Colton Life Science Advisors and EBD Group, two organizations that have a long and successful history building programs that meet the needs of the life science industry. For more information, visit www.ebdgroup.com/bts.
About Q Therapeutics, Inc.
Headquartered in Salt Lake City, Utah, Q Therapeutics, Inc. is a fully reporting, non-trading company, engaged in developing adult stem cell therapies to treat debilitating diseases of the central nervous system. The Company's first product, Q-Cells®, is a cell-based therapeutic intended to restore or preserve normal activity of neurons by providing essential support functions that occur in healthy central nervous system tissues. Q-Cells may be applicable to a wide range of central nervous system diseases, including demyelinating conditions such as multiple sclerosis, transverse myelitis, cerebral palsy and stroke; as well as other neurodegenerative diseases and injuries, such as ALS (Lou Gehrig's disease), spinal cord injury, Parkinson's disease and Alzheimer's disease. Q Therapeutics' initial clinical target is ALS, with a first IND submission expected in 2013. For more information, visit www.qthera.com.
- Investment & Company Information
- San Francisco
- central nervous system